Format
Sort by
Items per page

Send to

Choose Destination

Best matches for bipolar disorder hepatitis c:

Bipolar disorder and interferon treatment: how to manage? Aalouane R et al. Eur J Gastroenterol Hepatol. (2013)

Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment. Kelly EM et al. Eur J Gastroenterol Hepatol. (2012)

Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder. Lin HC et al. PLoS One. (2017)

Search results

Items: 1 to 20 of 66

1.

Association of viral hepatitis and bipolar disorder: a nationwide population-based study.

Chong LW, Hsu CC, Lee CY, Chou RH, Lin CL, Chang KH, Hsu YC.

J Transl Med. 2018 Jun 22;16(1):173. doi: 10.1186/s12967-018-1542-3.

2.

Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden.

Bauer-Staeb C, Jörgensen L, Lewis G, Dalman C, Osborn DPJ, Hayes JF.

Lancet Psychiatry. 2017 Sep;4(9):685-693. doi: 10.1016/S2215-0366(17)30253-5. Epub 2017 Jul 4.

3.

Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.

Lin HC, Xirasagar S, Lee HC, Huang CC, Chen CH.

PLoS One. 2017 Jun 16;12(6):e0179312. doi: 10.1371/journal.pone.0179312. eCollection 2017.

4.

The changing epidemiology of HIV in the criminal justice system.

Baillargeon J, Pulvino JS, Leonardson JE, Linthicum LC, Williams B, Penn J, Williams RS, Baillargeon G, Murray OJ.

Int J STD AIDS. 2017 Nov;28(13):1335-1340. doi: 10.1177/0956462417705530. Epub 2017 Apr 27.

PMID:
28449629
5.

Psychiatric readmissions and their association with physical comorbidity: a systematic literature review.

Šprah L, Dernovšek MZ, Wahlbeck K, Haaramo P.

BMC Psychiatry. 2017 Jan 3;17(1):2. doi: 10.1186/s12888-016-1172-3. Review.

6.

Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review.

Machado MO, Oriolo G, Bortolato B, Köhler CA, Maes M, Solmi M, Grande I, Martín-Santos R, Vieta E, Carvalho AF.

J Affect Disord. 2017 Feb;209:235-245. doi: 10.1016/j.jad.2016.11.039. Epub 2016 Nov 27. Review.

PMID:
27936453
7.

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment.

Tang LS, Masur J, Sims Z, Nelson A, Osinusi A, Kohli A, Kattakuzhy S, Polis M, Kottilil S.

World J Hepatol. 2016 Nov 8;8(31):1318-1326.

8.

Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.

Carey KJ, Huang W, Linas BP, Tsui JI.

J Subst Abuse Treat. 2016 Jul;66:54-9. doi: 10.1016/j.jsat.2016.01.009. Epub 2016 Feb 13.

9.

Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers.

Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C.

Am J Public Health. 2016 Apr;106(4):740-2. doi: 10.2105/AJPH.2016.303059. Epub 2016 Feb 18.

10.

Mental health problems in people living with HIV: changes in the last two decades: the London experience 1990-2014.

Adams C, Zacharia S, Masters L, Coffey C, Catalan P.

AIDS Care. 2016;28 Suppl 1:56-9. doi: 10.1080/09540121.2016.1146211. Epub 2016 Feb 17.

11.

Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders.

Su KP, Matsuoka Y, Pae CU.

Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):129-37. doi: 10.9758/cpn.2015.13.2.129.

12.

Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.

Wyles D, Pockros P, Morelli G, Younes Z, Svarovskaia E, Yang JC, Pang PS, Zhu Y, McHutchison JG, Flamm S, Lawitz E.

Hepatology. 2015 Jun;61(6):1793-7. doi: 10.1002/hep.27814. Epub 2015 Apr 27.

PMID:
25846014
13.
14.

SSI. ALJ failed to show reason for limiting weight of physicians.

[No authors listed]

AIDS Policy Law. 2014 Jul;29(8):6. No abstract available.

PMID:
25151685
15.

Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.

Wu JY, Shadbolt B, Teoh N, Blunn A, To C, Rodriguez-Morales I, Chitturi S, Kaye G, Rodrigo K, Farrell G.

J Gastroenterol Hepatol. 2014 Jun;29(6):1258-64.

PMID:
24955454
16.

SSI. ALJ failed to properly evaluate woman's medical records.

[No authors listed]

AIDS Policy Law. 2013 Oct;28(11):5. No abstract available.

PMID:
24563955
17.

Impulsiveness in chronic hepatitis C patients.

Fábregas BC, Abreu MN, Dos Santos AK, Moura AS, Carmo RA, Teixeira AL.

Gen Hosp Psychiatry. 2014 May-Jun;36(3):261-5. doi: 10.1016/j.genhosppsych.2013.12.006. Epub 2013 Dec 24.

PMID:
24456821
18.

Understanding preventive health screening services use in persons with serious mental illness: how does integrated behavioral health primary care compare?

Xiong GL, Iosif AM, Suo S, Mccarron RM, Koike A, Onate J, Carter CS.

Int J Psychiatry Med. 2015;48(4):279-98. doi: 10.2190/PM.48.4.d.

PMID:
25817524
19.

Bipolar disorder and interferon treatment: how to manage?

Aalouane R, Hafidi H, Rammouz I.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):1002. doi: 10.1097/MEG.0b013e32835f5a71. No abstract available.

PMID:
23817449
20.

A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.

Sockalingam S, Blank D, Banga CA, Mason K, Dodd Z, Powis J.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1377-84. doi: 10.1097/MEG.0b013e3283624a28.

PMID:
23680911

Supplemental Content

Loading ...
Support Center